NewGenIVF Group (NIVF)
Provides fertility treatment and referral services in Thailand, Cambodia, and Kyrgyzstan.
NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor
BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026.
NewGen Provides Update on K25.ai Investment and Strengthened Financial Position
NewGen's total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization NewGen's agreed 13% stake in K25.ai is now valued at approximately US$26 million, based on K25.ai's recently closed Series A investment round, representing an unrealized gain of about US$8.5 million BANGKOK, July 30, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today provided an update on its strategic investment in K25.ai and the related impact on the Company's capitalization and financial position. NewGen reported net profit attributable to shareholders of US$9.9 million for the fiscal year ended December 31, 2025, with net assets of approximately US$25.98 million as of that date.
NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million
Follow-on investment would increase NewGen's aggregate ownership to 13% Follow-on investment would increase NewGen's aggregate ownership to 13%
NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million
K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million NewGen's 10% ownership stake in K25.ai has reached US$20 million in value and generated a ~US$10 million unrealized gain, expected to be booked in 2026 BANGKOK, July 23, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today highlighted that K25.ai has closed its Series A investment round with strategic support from the Singapore-based digital assets firm Amber Group. The latest round values K25.ai at a post-money valuation of US$200 million, doubling its US$100 million Pre-A valuation in under 60 days.
K25.ai Secures Series A Investment with Strategic Support from Amber Group, Valuation Doubles to US$200 Million
/PRNewswire/ -- K25.ai, the AI-native prediction market transforming livestreams into real-time interactive markets, today announced the closing of its Series
NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
Strong Capitalization Foundation Supports Strategic Growth and Market Stability Strong Capitalization Foundation Supports Strategic Growth and Market Stability
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
K25. ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen's expanded stake and exclusive Asia-Pacific agency rights deepen its strategic participation in K25.
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion
NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure
NewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure
NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy
NewGen's 6% Stake in K25.ai Now Valued at US$6 Million Company will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.
NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation
BANGKOK and SINGAPORE, May 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGenIVF” or the “Company”), a technology-driven, diversified growth company, today announced that it has entered into a strategic investment agreement with K25.ai, an APAC-focused AI-powered watch-to-predict platform led by Mr. Andy Cheung, former Chief Operating Officer of OKX and former Chief Executive Officer of Groupon Hong Kong.
NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress
NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the “2025 Annual Report”) which was filed with the U.S. Securities and Exchange Commission (the “SEC”) in April 2026.
Contrasting NewGenIvf Group (NASDAQ:NIVF) and BrightSpring Health Services (NASDAQ:BTSG)
BrightSpring Health Services (NASDAQ: BTSG - Get Free Report) and NewGenIvf Group (NASDAQ: NIVF - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Risk and Volatility BrightSpring Health Services has
NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Up 80.4% in February
NewGenIvf Group Limited (NASDAQ: NIVF - Get Free Report) was the target of a significant increase in short interest in February. As of February 27th, there was short interest totaling 19,795 shares, an increase of 80.4% from the February 12th total of 10,974 shares. Currently, 3.0% of the company's stock are short sold. Based on an
NewGen and Evident Capital Successfully Activate Commitment Campaign for Inaugural Tokenized Real Estate Bond, Delivering on Cross-Border Real World Asset Financing Strategy
Rapid progress from announcement of successful launch in under two weeks signals NewGen's expertise and commitment Launch represents fulfilment of NewGen's goals to spearhead Real World Asset tokenization, puts Company at the forefront of digital assets innovation BANGKOK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, is pleased to announce that the Commitment Campaign for its inaugural tokenized bond issuance is now live on Evident Capital's SFC-licensed, Hong Kong-based tokenization and alternative assets platform. This activation delivers on the commitments outlined in the Company's January 21, 2026 announcement, where it appointed award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel and formally engaged Evident Capital, and did so in record time, moving from announcement to live investor engagement in under two weeks.
NewGen to Execute Up to US$2 Million Share Repurchase Program Through Benchmark
Management reiterates strong confidence in NewGen's long-term fundamentals and disciplined capital allocation strategy Management reiterates strong confidence in NewGen's long-term fundamentals and disciplined capital allocation strategy
NewGenIvf Group (NASDAQ:NIVF) Shares Scheduled to Reverse Split on Monday, January 26th
NewGenIvf Group Limited (NASDAQ: NIVF)'s stock is set to reverse split on the morning of Monday, January 26th. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, January 25th. NewGenIvf Group Trading Down 4.6% Shares of NIVF stock opened
NewGenIvf Group (NASDAQ:NIVF) & Oncology Institute (NASDAQ:TOI) Head-To-Head Survey
NewGenIvf Group (NASDAQ: NIVF - Get Free Report) and Oncology Institute (NASDAQ: TOI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations. Institutional and Insider Ownership 66.2% of NewGenIvf
NewGen Announces Up to US$2 Million Share Repurchase Program
BANGKOK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its Board of Directors (the “Board”) has authorized a share repurchase program under which the Company may repurchase up to US$2 million of its outstanding Class A ordinary shares over the next 24 months (“Share Repurchase Program”). The Company plans to adopt and implement this Share Repurchase Program in accordance with applicable rules and requirements under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Company's insider trading policy.
NewGenDigital Appointed as SAXA Inc.'s Agent for Tokenization of US$100 Million of Gold-backed Assets
Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA's worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be expanded to US$1 billion under the terms of the agreement; NewGenDigital to earn 5% commission on assets sold BANGKOK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its subsidiary, NewGenDigital Limited (“NewGenDigital”), has signed an engagement letter effective October 30, 2025 with SAXA, Inc. (“SAXA”) to act as the worldwide agent for the tokenization of an initial US$100 million tranche of SAXA's gold-backed assets. The agreement, which is contractually binding upon execution of the engagement letter, represents part one of a two-part transaction.